‘A rising tide scenario’: Why other Big Pharmas could follow Lilly into psychedelics

Velocity

How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →

Coverage (3)

• ATAI Stock Slips After Blockbuster Week: Cathie Wood Calls $3.8B Lilly Deal ‘Well-Deserved’ Return For Shareholders Stocktwits · 1d ago
• Big Pharma And Psychedelic Medicine: Eli Lilly’s $3.8 Billion Bet Forbes · 1d ago
• Lilly’s AtaiBeckley buy validates space as Big Pharma takes note of psychedelics BioSpace · 1d ago

Related trends